Bolt Biotherapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Bolt Biotherapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $11.70 million for the year ending 2025.

  • Bolt Biotherapeutics, Inc. showed an increase of +62.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Bolt Biotherapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Bolt Biotherapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 111.2%.
  • Historical annual values: Fiscal year 2025: $11.70 million | Fiscal year 2024: $7.21 million | Fiscal year 2023: $10.81 million | Fiscal year 2022: $9.24 million | Fiscal year 2021: $27.38 million | Fiscal year 2020: $5.54 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: